BCAA 8:1:1 – 200 Caps
BCAA 8: 1: 1 Beverly Nutrition is the most advanced formula branched amino acids in the ratio 8:1:1 (8 parts of Leucine, 1 of Isoleucine and 1 of Valine), a powerful and advanced combination of BCAAs that are important for muscle growth and recovery. BCAA 8:1:1 intake can also benefit during extreme diets reducing the catabolic effect on muscle tissue because it has been formulated in capsules to obtain a progressive and complete assimilation.
The BCAA 8: 1: 1 branched amino acids (leucine, isoleucine and valine) are essential amino acids and form almost a third of the amino acids that are present in proteins of skeletal muscle. While most of the amino acids can only be used as an energy source in the liver, branched amino acids can be used directly by the muscle, so that amino acids consumed during training or competition have different advantages and improve performance, favour recovery, stimulate protein synthesis, prevent muscle catabolism and define your muscle mass.
The consumption of five daily doses of BCAA 8: 1: 1 provides 143% RDA of vitamin B6 which helps in the normal metabolism of proteins and glycogen. It participates in energy production and promotes physical and mental wellbeing, intervening in the functioning of the immune system and energy production.
INGREDIENTS: L – Isoleucine, L – Leucine, L – Valine and Vitamin B6.
Packaging: 200 Capsules
DIRECTIONS: As a dietary supplement, take five capsules after training or as recommended by nutritionist
DATASHEET: BCAA 8.1.1 200 CAP
LEGAL NOTE: Products reviewed here are food supplements or as established by European Directive 2002/46/EC on food supplements and all can be legally sold in all countries of the European Community, under Articles 28, 29 and 30 of the treaty the European Community and by Articles 1 to 4 of the European Parliament Decision 3052/95/EC number. Dietary supplements are not trying to replace a balanced and varied diet, are presented only in order to supplement the intake of nutrients of a normal diet. Neither treat, prevent, diagnose or cure any disease, acts attributable to drugs, as defined by European Directive 2004/27/EC of 31 March, the Council and European Parliament on medicinal products.